European Toxin Limits, USDA's Fly Strategy, and Global Medical Advances: A Health News Roundup

This comprehensive health news overview covers the EU's updated toxin limits for baby formula, the USDA's fly release to combat screwworm pests, and the latest in pharmaceutical trials and regulatory actions. It also highlights a groundbreaking face transplant in Spain and industrial strikes by doctors in England.

The European food safety watchdog's recommendation to cap cereulide toxin levels in infant formulas has led several French producers to recall affected batches. The toxin, sourced from a Chinese supplier, poses health risks, prompting major formula makers like Nestle, Danone, and Lactalis to scrutinize their supply chains.

The USDA is ramping up efforts to prevent the spread of screwworm pests in southern Texas and along the U.S.-Mexico border by releasing sterile, genetically modified flies. This initiative aims to protect livestock from these flesh-eating parasites, which could devastate agricultural sectors if left unchecked.

In medical advancements, a Spanish hospital made headlines with a pioneering face transplant from a donor who opted for assisted dying, while in regulatory news, the FDA rejected Aquestive's allergy treatment due to packaging concerns, impacting its market entry strategy. Meanwhile, pharmaceutical firms such as Sanofi and Novo Nordisk continue to navigate challenges and breakthroughs in drug trials.

(With inputs from agencies.)